Active Ingredient History

  • Now
Vadadustat is an experimental medication which acts as a HIF prolyl-hydroxylase inhibitor and thereby increases endogenous production of erythropoietin, which stimulates production of hemoglobin and red blood cells. It is in Phase III clinical trials for the treatment of anemia caused by chronic kidney disease.   Wikipedia

  • SMILES: OC(=O)CNC(=O)c1ncc(cc1O)c2cccc(Cl)c2
  • Mol. Mass: 306.71
  • ALogP: 1.92
  • ChEMBL Molecule:
More Chemistry
akb-6548 | pg-1016548 | vadadustat


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue